Open AccessSelective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
Author(s) -
Sherin Thalappil,
Maryam AlNesf
Publication year - 2022
Publication title -
qatar medical journal
Language(s) - English
Resource type - Journals
eISSN - 2227-0426
pISSN - 0253-8253
DOI - 10.5339/qmj.2022.fqac.4
Subject(s) - medicine , cox 2 inhibitor , pharmacology , dermatology , cyclooxygenase , biochemistry , chemistry , enzyme